PubRank

Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 25952566)

Published in J Cardiovasc Electrophysiol on June 16, 2015

Authors

Mikhael F El-Chami1, Mathew Levy2, Heval M Kelli3, Mary Casey2, Michael H Hoskins1, Abhinav Goyal4, Jonathan J Langberg1, Anshul Patel1, David Delurgio1, Michael S Lloyd1, Angel R Leon1, Faisal M Merchant1

Author Affiliations

1: Division of Cardiology-Section of Electrophysiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
2: Emory Healthcare, Atlanta, Georgia, USA.
3: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
4: Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Articles citing this ↘

Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis. J Interv Card Electrophysiol (2016) 0.86

Sudden Cardiac Death Among Hemodialysis Patients. Am J Kidney Dis (2017) 0.78

Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc (2016) 0.75

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft. HeartRhythm Case Rep (2016) 0.75